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Isolation and Characterization of a Laminin-binding Protein 
from Rat and Chick Muscle 
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Howard Hughes Medical Institute and Department ofPhysiology, University of California, San Francisco, California 94143-0724 
Abstract. A major laminin-binding protein (LBP), 
distinct from previously described LBPs, has been iso- 
lated from chick and rat skeletal muscle (Mr 56,000 
and 66,000, respectively). The purified LBPs from the 
two species were shown to be related antigenically and 
to have similar NH2-terminal amino acid sequences 
and total amino acid compositions. Protein blots using 
laminin and laminin fragments provided evidence that 
this LBP interacts with the major heparin-binding do- 
main, E3, of laminin. Studies on the association of 
this LBP with muscle membrane fractions and recon- 
stituted lipid vesicles indicate that this protein can in- 
teract with lipid bilayers and has properties of a pe- 
ripheral, not an integral membrane protein. These 
properties are consistent with its amino acid sequence, 
determined from cDNAs (Clegg et al., 1988). Exami- 
nation by light and electron microscopy of the LBP 
antigen distribution in skeletal muscle indicated that 
the protein is localized primarily extracellularly, near 
the extracellular matrix and myotube plasmalemma. 
While a form of this LBP has been identified in heart 
muscle, it is present at low or undetectable l vels in 
other tissues examined by immunocytochemistry indi- 
cating that it is probably a muscle-specific protein. As 
this protein is localized extracellularly and can bind to 
both membranes and laminin, it may mediate myotube 
interactions with the extracellular matrix. 
I 
NDIVIDUAL skeletal muscle fibers are surrounded by 
basement membranes which contain collagens IV and 
V, laminin, fibronectin, and proteoglycans (Sanes and 
Cheney, 1982; Kuhl et al., 1982). Although these compo- 
nents are common to all basement membranes, tructural 
and compositional differences exist between the basement 
membranes ofdifferent issues (Mohan and Spiro, 1986). In 
addition, the basement membranes within a tissue may ex- 
hibit anatomical specialization. For example, the muscle 
basal amina is specialized in the region of the neuromuscu- 
lar junction. The asymmetric forms of acetylcholinesterase 
and several other basement membrane molecules have a 
differential distribution between onneuromuscular junction 
membrane and the neuromuscular junction (McMahan et 
al., 1978; Sanes and Hall, 1979; Sanes and Cheney, 1982; 
Sanes and Chiu, 1983). The muscle basal amina accumu- 
lates during muscle development and is gradually remodeled 
to achieve an adult structure (Chiu and Sanes, 1984; Sanes 
et al., 1986). Experimental evidence suggests that myotube 
formation and interaction with both connective tissue ele- 
ments and neuronal elements influences basal amina forma- 
tion (Anderson, 1986; Nitkin et al., 1983; Olwin and Hall, 
1985; Sanderson et al., 1986; Sanes and Lawrence, 1983). 
Thus, the muscle basal amina is a complex structure which 
is remodeled during development and has important effects 
upon the biology of the myotube and adjacent tissues. 
Laminin, an abundant basement membrane component 
(Timpl et al., 1979), has been shown to potentiate cell attach- 
ment and spreading, cell migration, and neurite outgrowth 
(reviewed in Liotta et al., 1986). Two distinct types of cell 
surface molecules have been postulated as mediators of cell 
interaction with laminin. They differ in apparent molecular 
weight and in affinity for laminin. Representatives of both 
types of laminin receptor have been demonstrated in skeletal 
muscle (Lesot et al., 1983; Horwitz et al., 1985). The lower 
affinity receptor was first identified by antibodies (CSAT and 
JG22) that blocked cell attachment to different extracellular 
matrix protein substrates (Greve and Gottlieb, 1982; Neff et 
al., 1982). These matrix receptors appear to be heterodi- 
mers, with apparent molecular masses between 110 and 200 
kD, and are members of a super family of cell surface recep- 
tors, now named the integrins (Hynes, 1987; Ruoslahti and 
Pierschbacher, 1987). Members of this family interact with 
a wide variety of extracellular matrix glycoproteins. They 
also contain cytoplasmic domains that bind proteins associ- 
ated with the cytoskeleton (Horwitz et al., 1986). Individual 
integrins appear to be developmentally regulated in some tis- 
sues (Hall et al., 1987). 
Members of the other major group of laminin-binding pro- 
teins (LPBs) ~, sometimes referred to as the high affinity re- 
ceptors, bind to laminin with apparent affinities in the 
nanomolar range (Malinoff and Wicha, 1983; Terranova et 
al., 1983; Rao et al., 1983) and have apparent Mr of 68,000- 
72,000 when measured by SDS-PAGE in reducing condi- 
1. Abbreviation used in this paper: LBP, laminin-binding protein. 
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tions (Lesot et al., 1983; Malinoff and Wicha, 1983; Ter- 
ranova et al., 1983; Rao et al., 1983). These proteins have 
been isolated from murine melanoma cells (Rao et al., 
1983), murine fibrosarcoma cells (Malinoff and Wicha, 
1983), human breast carcinoma cells (Terranova et al., 1983; 
Barsky et al., 1984), as well as from skeletal muscle (Lesot 
et al., 1983) primarily by affinity chromatography on lami- 
nin. Monoclonal antibodies against the breast cell carcinoma 
laminin receptor inhibited the binding of radiolabeled lami- 
nin to carinoma cells (von der Mark and Kuhl, 1985; Liotta 
et al., 1985) and polyclonal anti-laminin receptor antibodies 
appear to inhibit myoblast and melanoma cell attachment to 
laminin substrates (von der Mark and Kuhl, 1985; Wewer et 
al., 1987). In addition, a 120-kD membrane glycoprotein 
that is present in NG108-15 cells, chicken brain and mouse 
3T3 fibroblasts interacts strongly with laminin and may rep- 
resent a new type of cell surface/laminin-binding molecule 
(Smalheiser and Schwartz, 1987). 
The goal of the present study was to purify large quantities 
of the major muscle LBPs to allow characterization f their 
distributions, laminin- and membrane-binding properties 
and cellular functions. A major LBP isolated by this proce- 
dure has properties that distinguish it from the two previ- 
ously identified laminin receptors described above. 
Materials and Methods 
Materials 
Adult White Leghorn chickens were obtained from Feather Hill Farm 
(Petaluma, CA). New Zealand White rabbits and rats were from Simonson 
Laboratories (Gilroy, CA). Affigel 10 Sepharose, and hydroxyapatite (HA) 
(DNA grade Bio-Gel HTP) were obtained from Bio-Rad Laboratories 
(Richmond, CA). Protein A Sepharose was from Pharmacia Fine Chemi- 
cals, Piscataway, NJ. DEAE-cellulose (DE-52) was purchased from the 
Whatman Company, (England). Thin layer chromatography plates and 
X-Omat film were from Kodak. En3Hance was from Dupont (Wilmington, 
DE). Trypsin (238 U/rag) and horseradish peroxidase-conjugated goat 
anti-rabbit antiserum were from Cooper Biomedical (Malvern, PA). 
Nitrocellulose filters were from Schleicher & Schuell (Keene, NH). Iodo- 
gen was from Pierce Chemical Company (Rockford, IL). NalZ~I (16.7 
mCi/lag) was from Amersham Corp. (Arlington Heights, IL) and [35S]me- 
thionine was from ICN Radiochemicals (Irvine, CA). Egg lecithin was from 
Avanti Polar Lipids (Birmingham, AL). Gold-conjugatexl goat anti-rabbit 
antibody (AuroProbe EM GAR G20) was from Janssen Life Sciences Prod- 
ucts (Piscataway, N J). Lowicryl K4M was from Polysciences, Inc. (War- 
rington, PA). All other chemicals and biochemicals were from Sigma 
Chemical Company (St. Louis, MO). 
LBP Purification 
Extraction. Leg muscle tissue was homogenized in a Waring blender (3 × 
30 s) in 4 vol ice-cold homogenization buffer (10 mM Tris-HCl, 10 mM 
NaCI, 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM benzamidine, 
and 1 mM EDTA, pH 7.4. All subsequent operations, except where noted, 
were performed at 4°C. The homogenate was filtered through one layer of 
gauze then centrifugated at 25,000 g for 30 min. The supernatant was dis- 
carded and the pellet resuspended in the same buffer by homogenization 
using a Polytron (2 x 20 s). The sample was recentrifuged and the pellet 
dissolved (by Polytron) in the above buffer plus deoxycholate to a final con- 
centration of 0.25 %. After a 30-min incubation on ice the solution was cen- 
trifuged at 25,000 g for 45 min. The supernatant solution was saved and the 
pellet was extracted tv~ additional times with the deoxycholate containing 
extraction buffer. 
Ion Exchange Chromatography. The deoxycholate extract supernatants 
were pooled and the NaCI concentration was adjusted to 0.1 M by the addi- 
tion of solid NaCI. This sample was applied to a DEAE-cellulose column 
(4.0 × 8.0 cm) equilibrated with 10 mM Tris-HCI, 0.1 M NaCI and 0.1% 
NP40, pH 7.4. The column was washed with 8-10 column volumes of the 
loading buffer and then with a buffer of identical composition except for a 
higher concentration f NaCI, 0.2 M and 0.25 M for columns loaded with 
rat and chick extracts respectively. The LBP was eluted from the DEAE- 
cellulose column with either 0.6 M NaCI (rat) or with 0.5 M NaCI (chick) 
at a flow rate of 30 ml/h. The last purification step differed for the rat and 
chick LBP: Concanavalin A chromatography for the rat LBP and hydrox- 
ylapatite chromatography for the chick LBP. 
Concanavalin A Chromatography. Rat muscle LBP was further purified 
by chromatography on Concanavalin A Sepharose (1.0 x 41.5 cm). The LBP 
recovered from the DE-52 column in 0.6 M NaCI was dialyzed into 10 mM 
Tris-HCI, 0.2 M NaC1, 0.1% NP40, pH 7.4 and applied to a Concanavalin 
A-Sepharose column equilibrated in the same buffer. The column was then 
washed extensively with the loading buffer. The LBP was eluted by rocking 
overnight in 10 mM Tris-HCl, 1 M NaCI, 0.1% NP40, 1 M tt-methyI-D- 
mannopyranoside, pH 7.4, in a larger column (2.5 x 15 cm). The eluate 
was dialyzed against 10 mM Tris-HCl, 0.15 M NaCI, 0.1% NP40, pH 7.4, 
concentrated by Amicon to 1 mg/ml, and was stored at -80°C. 
Hydroxylapatite Chromatography. Chick muscle LBP was further puri- 
fied by chromatography on hydroxylapatite at room temperature. The chick 
LBP recovered from the DEAE column in 0.5 M NaCI buffer was adjusted 
to a phosphate concentration f 0.2 M by the addition of 1.0 M NaPO4, pH 
7.4. It was then applied to an hydroxylapatite column (1.2 × 6.0 cm) equili- 
brated in 0.2 M NaPO4, pH 7.4, 0.1% NP40 at room temperature. The 
column was washed with at least 20 column volumes of loading buffer and 
was then eluted with a 200 ml 0.2-1.0 M NaPO4, pH 7.4, linear gradient 
(20 ml/h). Fractions containing the chick LBP were dialyzed against 10 mM 
Tris-HCl, 0.15 M NaCI, 0.1% NP40, pH 7.4, concentrated to "~1 mg/ml, 
and stored at -80°C. 
Preparation of Anti-LBP Antibodies 
Anti-LBP antibodies were raised in female New Zealand White rabbits by 
standard protocols (primary immunization with 400-500 I~g of protein in 
Freund's complete adjuvant; secondary immunization at da~' 7 and every 
30 d thereafter with 200-300 lag antigen in Freund's incomplete adjuvant). 
Aflinity purified anti-LBP antibodies were prepared by adsorption and elu- 
tion with 3 M NaSCN using a 1 ml LBP-Aliigel-10-Sepharose column con- 
taining •1 mg LBP. 
Immunohistocheraistry and Immunoelectronmicroscopy 
Frozen sections of rat skeletal muscle (5 p.M) were incubated with primary 
antibodies (15 p.g/ml) then peroxidase-conjugated second antibody, and di- 
aminobenzamidine by standard procedures (Graham and Karnovsky, 1966; 
Matthew et al., 1981). Controls, using affinity purified anti-P34 antibody, 
a major submaxillary gland protein of unknown function, and normal rabbit 
IgG were treated in the same manner. Rat heart and skeletal muscle were 
examined by post embedding staining of Lowicryl infiltrated sections using 
a modification of a previously described technique (Valentino et al., 1985). 
Sections were cut on a Reichart Ultracut E. Sections on grids were in- 
cubated with anti-LBP antibody (5 p.g/ml) or control antibody (anti-P34, 
22 Ixg/ml), rinsed, then incubated with gold-conjugated goat anti-rabbit 
IgG. The sections were viewed and photographed in a JEOL 100 B transmis- 
sion electron microscope. 
lmmunoprecipitation of the LBP 
Immunoprecipitation was performed using a modification of a previously 
described method (Kessler, 1981; John and Firestone, 1986). Extracts of 
metabolically labeled muscle plasma membranes, prepared as described be- 
low, were adjus~xl to 50 mM Tris-CI, 150 mM NaCI, 0.5% NP40, pH 7.4 
by the addition of concentrated reagents. Samples containing affinity puri- 
fied anti-LBP antibodies (30 Itg/ml), preimmune serum, and samples with- 
out antibody were incubated at 4°C for 2 h. Samples were preincubated with 
Sepharose 4B and the Protein A-Sepharose was preincubated with unla- 
beled muscle xtract to reduce nonspecific binding. After the samples were 
incubated with protein A-Sepharose for 1 h, the immunoprecipitates were 
collected by centrifugation a d were washed four times with 50 mM Tris- 
CI, 150 mM NaCI, 0.5% NP40, 0.05% SDS, 0.1% deoxycholate, pH 7.4. 
The pellets were dissolved in sample buffer and separated by SDS-PAGE. 
Gels were stained, destained, incubated in En3Hance then exposed to Ko- 
dak X-Omat film. 
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Protein Blots and Assays for 12~l-Laminin-binding 
and LBP Antigen 
Laminin and laminin fragments were prepared as previously described 
(Timpl et al., 1979; Ott et al., 1982) and iodinated by the Iodogen method 
(Fraker and Speck, 1978). Proteins were separated by SDS-PAGE as previ- 
ously described (Laemmli, 1970). Proteins were electrophoretically trans- 
ferred to nitrocellulose sheets (0.2-laM pore) in a Bio-Rad transfer apparatus 
using a current of 0.4 to 0.7 A for 2 h at 4°C (Towbin et al., 1979). Immuno- 
blotting and protein blotting followed a modification of a previously de- 
scribed technique (Bixby and Reichardt, 1985). After transfer, nitrocellu- 
lose sheets were "blocked" by incubation in blocking solution (1% BSA and 
0.4% hemoglobin in PBS; 100 mg/L CaCl2, 200 mg/L KC1, 200 mg/L 
K2SO4, 100 mg/L MgCI2 • 6 H20, 8 g/L NaCI, 2.16 g/L Na2HPO4 • 7 H20, 
pH 7.4) for 1 h at room temperature. After this blocking step the nitrocellu- 
lose was incubated with primary antibody (1/500 dilution of serum), or ra- 
dioiodinated ligands (1.8 × 107 cpm/ml aminin or laminin fragments) in 
blocking solution overnight at 4°C. The blots were then washed with 3 
changes of PBS over 15 min. Protein blots were then dried and exposed to 
Kodak X-Omat film at -80°C. Protein blotting with radioiodinated laminin 
was used to determine the specific activity of the LBP at different steps of 
the purification. Units of, LBP were calculated by comparing ~251-1aminin 
binding with various extracts or purified fractions to standard curves con- 
structed by measurement of binding to known amounts of purified LBP. A 
unit of LBP is defined as 1 mg/ml of pure LBP. Immunoblots were incubated 
with a 1:1,000 dilution of peroxidase-labeled second antibody (goat anti- 
rabbit lgG) in blocking solution for2 h at room temperature, then developed 
using H20., and 4-chloronapthol as described by Hawkes et al. (1982). 
Cell Culture and Radiolabeling 
Primary chick myoblast cultures were prepared from breast muscle of day 
l 1 chick embryos by the method of Antin et al. (1986). Cultures were main- 
tained in MEM with Earle's salts containing 10% horse serum, 2.5% em- 
bryo extract, 50 U/ml penicillin and 50 lag/ml streptomycin. Cells were 
plated on plates coated with 10 lag/ml aminin and maintained inculture for 
3 to 5 d. Cultures to be metabolically labeled were incubated overnight in 
methionine free culture medium containing 50-60 gCi/ml [35S]methionine 
and supplemented with 0.2 mM methionine. At the end of the labeling 
period cells were washed three times with Ca ++, Mg ++ free PBS, then col- 
lected by centrifugation. 
Preparation of Muscle Cell Plasma Membranes 
Chick muscle cells in culture were metabolically abeled with [35S]methio- 
nine as described above. The cell pellet was resuspended in 0.25 M sucrose, 
10 mM triethylamine HCI, 1 mM PMSE 1 mM N-etbylmaleimide, pH 7.4, 
and was homogenized in a Dounce homogenizer (Cates and Holland, 1978). 
The homogenate was centrifugated for 10 min at 1,700 g in a Sorvall SS-34 
rotor. The supernatant was saved and the pellet was rehomogenized in 1/2 
vol of the homogenization buffer and recentrifuged. The supernatants were 
pooled and centrifuged for 1 h at 33,000 g. The pellet from this step was 
resuspended in the homogenization buffer and separated by a three step su- 
crose gradient (40, 32, and 17%, wt/vol) (Lesot et al., 1983). The gradient 
was centrifuged for 3 h at 1"30,000 g in a Beckman SW27 rotor. Fractions 
containing membranes were identified by OD2so and peaks were pooled. 
The sucrose was diluted by the addition of triethylamine buffer without su- 
crose and membranes were collected by centrifugation at 150,000 g for 40 
rain at 4°C in a Beckman SW41 rotor. The membranes were aliquoted for 
different experimental treatments: 0.1 M NaOH, 4 M guanidine HCI, 20 
mM lithium diiodosalicylate (LIS), 5 mM NaEDTA, 1 M NaCI, or 10 mM 
Na,CO3. Individual samples were adjusted to these concentrations, thor- 
oughly mixed, and incubated at room temperature for 10 min. Samples were 
then centrifuged at 180,000 g in a Beckman airfuge to pellet he membranes. 
Supernatants and pellets were separately collected and immunoprecipitated 
with the anti-LBP antibody. After electrophoresis of the immunoprecipi- 
tates, fluorographs of the gels were scanned to quantify the relative amount 
of LBP in the supernatant and pellet from each sample. 
Reconstitution ofLBP with A rtificial Liposomes 
Protein-liposome interactions were measured as described previously 
(Doms et al., 1985). Liposomes were prepared by sonicating egg lecithin 
in 1 mM Tris-HCl, pH 7.5, for 15 to 20 min on ice (Racker et al., 1979). 
Purified chick LBP, radioiodinated by the Iodogen method (Fraker and 
Speck, 1978), was added to 45 I.tl of liposomes and incubated at room tem- 
perature for 1 h (5 lal containing 2-20 lag protein in 10 mM Tris-HCl, 0.1% 
NP40, pH 7.5). Different experimental gents were added at the end of this 
initial incubation and the protein liposome mixture was incubated for an ad- 
ditional hour at room temperature. The protein-liposome mixture was ad- 
justed to 1.5 ml 45% sucrose and overlaid with 2.0 ml 30% sucrose, and 
1.0 ml 10% sucrose. The samples were centrifuged at 200,000 g for 21 h 
at 4°C in a Beckman SW60 rotor. After centrifugation, fractions were col- 
lected and ~25I was quantitated in a Beckman Gamma 4000 counter. 
Protein Partitioning in Triton X-114 
The behavior of purified protein (LBP and two controls, glycophorin and 
BSA) in a 1% solution of Triton X-II4 was determined by incubating 125I- 
protein in 500 lal of 1% Triton X-II4, 10 mM Tris-HCl, 150 mM NaCI, 
pH 7.4, at room temperature for 10 rain. The two Triton X-I14 phases were 
separated by centrifugation at 11,000 g for 3 min at room temperature and 
the relative concentration of ~25I-protein i each phase was determined in
a Beckman Gamma 4000 counter. 
Protein Analysis 
Amino acid composition was performed on a Beckman 6300 amino acid an- 
alyzer as described for human insulin and IGF-I receptors (Fujita-Yama- 
guchi et al., 1986). NH2-terminal sequence analysis was performed by Ed- 
man degradation on a multiphase sequencer (McLean et al., 1986). N-linked 
oligosaccharides were removed by overnight incubation at 30°C in the pres- 
ence of 0.17% SDS, 5.0 mM NaEDTA, 1.25% NP40, 0.2 M NaPO4, pH 8.6, 
and 10 U/ml N-glycosidase E Protein concentrations were determined by 
the amido black method (Schaffner and Weissman, 1973). 
Results 
Purification of a Skeletal Muscle LBP 
To identify major LBPs in skeletal muscle, rat and chick 
skeletal muscle extracts were fractionated by SDS-PAGE 
and blotted onto nitrocellulose. The blots were incubated 
with t25I-laminin and examined for the presence of LBPs. 
Extraction and purification steps were optimized by follow- 
ing the LBP in this manner. The results revealed major LBPs 
of Mr 56,000 in chick muscle (Fig. l) and Mr 66,000 in rat 
muscle (data not shown). These proteins did not bind detect- 
able amounts of ~25I-fibronectin or J25I-collagen IV using the 
same assay (data not shown). The most prominent LBP in 
each extract was purified in quantities sufficient to allow bio- 
chemical characterization (see Table I and Fig. 2). The most 
effective purification i volved initial extraction of the muscle 
tissue in a buffer that did not solubilize the LBP and subse- 
quent extraction of the insoluble residue with a deoxycholate 
containing buffer that did effectively extract the LBR Deoxy- 
cholate xtracted greater than 50 % of the LBP present in the 
tissue; the remainder of the protein was present in an insolu- 
ble pellet, possibly associated with the extracellular matrix 
(Figs. l and 2). The deoxycholate extracts were chromato- 
graphed on DEAE-Cellulose. The LBPs from both chick 
and rat muscle were bound efficiently to DEAE-cellulose 
and were eluted with unusually high NaCl concentrations, 
resulting in more than 10-fold purification (Figs. 1 and 2; Ta- 
ble I). Rat LBP was eluted from DEAE-cellulose by 350 
mM NaC1 and chick LBP by 260 mM NaC1. Rat LBP was 
further purified by chromatography on Concanavalin A-Seph- 
arose and chick LBP was further purified by chromatography 
on hydroxylapatite. Table I shows the results of each purifi- 
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Figure 1. Autoradiograph of a t2SI-laminin protein blot. Purified 
avian LBP and samples from purification steps were separated by 
SDS-PAGE, electroblotted onto nitrocellulose, then blotted with 
]25I-laminin as described in Materials and Methods. Muscle ho- 
mogenate (lane 1), insoluble pellet (lane 2), deoxycholate extract 
(lane 3), DEAE-ceUulose bound fraction (lane 4 ), hydroxylapatite 
bound fraction (lane 5), purified LBP (lane 6) are shown. Different 
amounts of purified LBP; 400, 200, 100, 50, and 25 ng are shown 
in lanes 7through 11.The dried protein blot was exposed on Kodak 
X-Omat film. A photograph ofthe autoradiograph is shown. The 
position of molecular mass standards is shown on the left. 
cation step for both the rat and chick muscle purifications. 
SDS-PAGE analysis of samples taken after each purification 
step for both rat and chick is shown in Fig. 2. Both rat and 
chick LBP were isolated to an estimated purity of greater 
than 90%, with purifications of LBP activity of 230- and 
1,400-fold, respectively. From 100 g (wet weight) of muscle, 
the purification described above yielded 7.4 mg of the rat 
LBP and 4.7 mg of the chick LBP. As similar yields were 
obtained from each tissue, the difference in the purification 
factors probably reflects comparatively greater inactivation 
of the rat LBP activity during purification. The results in 
Figs. 1 and 2 show that the purified rat and avian LBPs ap- 
peared to have the same relative molecular masses as the ma- 
jor LBPs detected in crude muscle extracts. 
Characterization ofSkeletal Muscle LBP 
The purified LBP from rat muscle migrated on SDS-PAGE 
with an apparent Mr of 66,000 (Fig. 2, lane 5), similar in 
size to other previously described LBPs (Lesot et al., 1983; 
Malinoff and Wicha, 1983; Rao et al., 1983 and Terranova 
et al., 1983). The chick LBP has an apparent Mr of 56,000 
(Fig. 2, lane 10). In spite of the difference inrelative molecu- 
lar masses, these two proteins were found to be homologous 
by several criteria. First, amino acid composition analysis 
demonstrated that both proteins had unusual, but very simi- 
lar compositions (Table II). The abundance ofAsn/Asp and 
Gln/Glu was particularly striking. Second, the NH2-termi- 
nal amino acid sequences of the purified chick and rat LBPs 
were determined and were found to be 60% identical for the 
first twenty amino acid residues (Table Ill). Computer analy- 
sis of the two sequences using the Dayhoff MDM-78 matrix 
resulted in a significant alignment score of 9.384 (Dayhoff, 
1978). Thus, the chick and rat LBPs are very similar pro- 
teins. Finally, the proteins were also shown to be immuno- 
logically related. Polyclonal antisera raised against he rat 
muscle LBP cross reacted with the chick LBP (Fig. 3) and 
antisera raised against he chick LBP cross reacted with the 
rat muscle LBP (data not shown). 
Tissue Distribution of the LBP 
The affinity purified anti-LBP antibodies were also useful in 
determining the tissue distribution of the LBP. Tissue ex- 
tracts from rat and chick liver, brain, kidney, retina, and 
heart were analyzed by SDS-PAGE and immunoblot with the 
anti-LBP antibodies (data not shown). This tissue survey 
Table L Purification Table 
Rat muscle laminin-binding protein 
Purification Purification 
step Protein factor 
ml mg/ml mg U/ml U U 
Homogenate 500 42 21,000 0.18 90 0.0043 1 
Insoluble pellet 480 31 14,900 0.16 76.8 0.0052 1.2 
DOC extract 800 2.7 2,200 0.07 56.0 0.025 5.5 
DEAE effluent 45 1.1 49.5 0.81 36.5 0.74 172 
Con A effluent 22.5 0.33 7.4 0.33 7.4 1.00 232 
Chick muscle laminin-binding protein 
Purification Purification 
step Protein factor 
ml mg/ml mg U/ml U U 
Homogenate 500 30.6 15,300 0.022 11 0.0008 1 
Insoluble pellet 470 22.1 10,400 0.020 9.4 0.001 1.3 
DOC extract 800 2.8 2,200 0.010 8.4 0.004 5.4 
DEAE effluent 240 0.61 146 0.04 8.4 0.06 81 
HAP effluent 18 0.26 . 4.7 0.26 4.7 1.00 1390 
Purification Table for Rat and Chick LBP. Rat and chick muscle LBP were purified as described in Materials and Methods. At each major step of the two purifica- 
tions, protein concentrations and laminin-binding activities were measured as described in Materials and Methods to obtain the specific activity in units/milligram 
protein. The purification factor was calculated by comparing the units of activity per milligram of protein in each fraction. 
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Figure 2. SDS-PAGE of proteins obtained at ifferent steps of LBP 
purification. Proteins obtained at different purification steps of the 
rat (lanes 1-5) and chick (lanes 6-10) skeletal muscle LBP were 
separated by SDS-PAGE (10%) and stained with Coomassie Bril- 
liant Blue. Muscle homogenate (lanes I and 6), insoluble pellet 
(lanes 2 and 7), deoxycholate extract (lanes 3 and 8), DEAE-cellu- 
lose eluent (lanes 4 and 9) and either Concanavalin A eluent (lane 
5) or hydroxylapatite eluent (lane 10) are shown. Molecular mass 
standards are indicated on the left. 
demonstrated that only one other tissue, heart, had a detect- 
able amount of anti -LBP antibody reactive protein. Simi- 
larly, when poly A ÷ RNA samples from the same chick tis- 
sues were analyzed for the presence of LBP mRNA, only 
skeletal muscle and heart were found to have high levels of 
LBP transcripts (Clegg et al., 1988). However, the heart pro- 
tein had an apparent molecular mass of 56,000 in both rat and 
chick (Fig. 3). Thus, in rat the skeletal muscle and heart 
muscle forms of the LBP differed in apparent molecular 
mass (66,000 and 56,000, respectively), while in chick the 
two forms were of similar molecular mass (56,000). This 
difference is not due to differential N-glycosylation since 
treatment with N-glycosidase F reduced the apparent 
molecular mass of both forms by ~2,000 (Clegg et al., 
1988). 
To demonstrate he synthesis of LBP by muscle cells, em- 
Table IlL Comparison f the NH2-Terminal Sequences of 
the Rat and Chick Skeletal Muscle LBPs 
1 2 3 4 5 6 7 8 9 10 
Rat Glu Asp Gly Leu Asp Phe Pro Glu Tyr Asp 
Chick Glu Glu Gly Leu Asn Phe Pro Thr Tyr Asp 
I 1 12 13 14 15 16 17 18 19 20 
Rat Gly Vai Asp Arg Val Iie Asn Val Ala Asp 
Chick Gly Lys Asp Arg Val Ile Asp Leu Asn Glu 
The NH2-terminal mino acid sequences of purified rat and chick skeletal 
muscle LBP were determined by Edman degradation a multiphase - 
quencer. 
bryonic chick skeletal muscle cells were grown in culture 
and metabolically labeled with [35S]methionine. LBP was 
isolated from membrane fractions purified as above and im- 
munoprecipitated with the anti-LBP antiserum. Results in 
Fig. 4 show the presence of a labeled band which comigrates 
with purified LBP and was specifically precipitated by the 
anti-LBP antiserum. Thus the chick skeletal muscle LBP is 
clearly synthesized by chick skeletal muscle cells. 
The LBP is Localized Near the Plasma Membrane In 
the Extracellular Matrix and has Characteristics ofa 
Peripheral Membrane Protein 
Laminin is localized in the basement membrane which sur- 
rounds individual myotubes. To determine whether the LBP 
had a similar distribution, sections of rat muscle were im- 
munostained with the anti-LBP antibody followed by a sec- 
ond antibody linked to peroxidase. The results, presented in 
Fig. 5, indicated that this LBP has a pericellular distribution 
similar to that of laminin (Sanes and Cheney, 1982). Exter- 
Table II. Amino Acid Composition of Rat and Chick LBP 
Amino acid Rat Chick 
mol % mol % 
Asp/Asn 19.7 20.0 
Ser 3.2 3.2 
Thr 3.9 3.8 
Glu/Gln 18.3 15.0 
Pro 5.1 4.2 
Gly 5.0 6.2 
Ala 7.0 5.2 
Val 6.0 6.3 
Met 1.2 1.3 
lie 4.8 7.4 
Leu 8.8 8.3 
Tyr 2.8 2.2 
Phe 3.4 4.2 
His 1.6 2.0 
Lys 6.9 7.0 
Arg 2.0 3.0 
Amino acid composition f rat and chick LBP. The amino acid composition f 
the rat and chick skeletal muscle LBPs is shown in mole percent. The amino 
acid composition f the purified proteins was determined byhydrolysis and 
analysis on a Beckman 6300 amino acid analyzer as described in Materials and 
Methods. 
Figure 3. Immunoblot of rat 
and chick skeletal muscle LBP 
and rat and chick heart LBE 
Rat and chick tissues were 
homogenized in electropho- 
resis sample buffer, boiled, 
centrifuged toremove particu- 
late material then separated 
by electrophoresis on a 10% 
SDS-PAGE under reducing 
conditions. After electropho- 
resis, proteins were transferred 
to nitrocellulose and prepared 
for immunoblot as described 
in Materials and Methods. 
Affinity purified anti-rat LBP 
antibody was incubated with 
this blot and bound antibodies 
were detected as described in 
Materials and Methods. Rat 
skeletal muscle (lane 1), rat 
heart (lane 2), chick skeletal 
muscle (lane 3), and chick 
heart (lane 4) are shown. 
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Figure 4. Skeletal muscle LBP is 
synthesized by muscle cells in cul- 
ture. Chick myoblasts were main- 
tained in culture and metabolically 
labeled with [35S]methionine as de- 
scribed in Materials and Methods. 
Proteins were immunoprecipitated 
with anti-LBP antibody (lane 1 ) or 
preimmune serum (lane 2) and sepa- 
rated by SDS-PAGE (10% polyacryl- 
amide, reducing conditions). A pho- 
tograph of the fluorograph is shown. 
Molecular mass standards are indi- 
cated on the left. 
nal radiolabeling with 125I and immunoprecipitation con- 
firmed an external surface localization for the LBP (data not 
shown). Immunoelectron microscopy showed that the LBE 
detected using colloidal gold-conjugated IgG, was present 
extracellularly near the muscle plasma membrane and ex- 
tracellular matrix (Fig. 6). It was not possible in this experi- 
ment to determine whether the rat LBP was primarily asso- 
ciated with the plasma membrane or the extracellular matrix. 
The nature of the possible interaction of the LBP with the 
muscle plasma membrane was of particular interest since 
such a localization would place the LBP in a position to 
mediate cell interactions with laminin in the extracellular 
matrix or to modulate the interactions of laminin with other 
cell surface molecules. Two types of experiments were de- 
signed to analyze whether the LBP was associated with the 
muscle plasma membrane. The first involved determining 
whether purified muscle plasma membranes contained as- 
sociated LBP and what the nature of the association was. 
Purified muscle plasma membrane fractions were isolated 
by sucrose density gradient fractionation from cultured 
embryonic hick muscle cells metabolically labeled with 
[35S]methionine (Cates and Holland, 1978). Neural cell ad- 
hesion molecule (NCAM), a known plasmalemma-associ- 
ated protein, was detected in these fractions by immunopre- 
cipitation with anti-NCAM antibodies (data not shown; 
Covault and Sanes, 1986). 35S-LBP could be immunopre- 
cipitated from these membranes with anti-LBP antibodies, 
showing that it was present in the purified chick myotube 
membrane fraction (see Fig. 4). To determine the nature of 
its association with these membranes, aliquots of purified 
muscle membrane were treated with reagents known to per- 
turb protein-membrane i teractions (Steck and Yu, 1973). 
Figure 5. Photomicrographs 
of rat skeletal muscle sections 
stained with anti-LBP and 
control antibodies. Skeletal 
muscle was excised, quick 
frozen, sectioned ona freez- 
ing microtome and prepared 
for peroxidase immunocyto- 
chemistry as described in Ma- 
terials and Methods. Muscle 
sections were photographed 
after incubation with either 
anti-LBP antibody (,4, bright 
field; B, phase contras0 or, as 
a control, anti-P34 antibody 
(C, bright field; D, phase con- 
trast). Note dark peroxidase 
staining product localizing the 
LBP between muscle fibers in 
the anti-LBP (A and B) but 
not in the control antibody (C 
and D) sections. 
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Figure 6. Electron micro- 
graphs of the rat skeletal mus- 
cle and heart reacted with an- 
ti-LBP antibody and visualized 
with colloidal gold-conjugat- 
ed secondary antibody. Rat 
muscle was excised and pro-
cessed for immunoelection 
microscopy as described (Ma- 
terials and Methods). Skeletal 
muscle was incubated with ei- 
ther anti-LBP antibodies (A) 
or control antibody (anti-P34) 
(B); heart muscle was incu- 
bated with anti-LBP antibody 
(C) or control antibody (an- 
ti-P34) (D). Primary antibody 
was visualized by incubation 
with gold-conjugated goat an- 
ti-rabbit secondary antibody. 
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Figure 7. Determination of conditions which remove LBP from 
muscle membranes. Rat muscle membranes were isolated from 
metabolically labeled cells as described in Materials and Methods. 
Aliquots of these membranes were mixed with dissociative reagents 
including 1 M NaC1, 10 mM lithium iodosalicylate (L/S), 5 mM 
NaEDTA, 0.1 N NaOH, 4 M guanidine HCI (GuHCI) and 20 mM 
Na2CO3. Untreated and experimental membrane samples were 
centrifuged to separate membrane bound from solubilized LBP. 
The supernatants and pellets were separately collected and the LBP 
was quantified byimmunoprecipitation with anti-LBP serum. The 
immunoprecipitates were separated by electrophoresis, gels were 
prepared for fluorography and exposed to Kodak X-Omat film. 
Fluorographs were scanned and the relative amount ofLBP in the 
supernatant (cross-hatched bars) nd pellet (open bars) were deter- 
mined. The data shown is the average of three separate experiments, 
the error bars indicate SEM. 
These included high pH (0.1 M NaOH), high ionic strength 
(1 M NaCI), a chaotropic agent (4 M guanidine HC1), a 
membrane perturbant (20 mM lithium diiodosalicylate, 
LIS), 5 mM NaEDTA and 10 mM Na2CO3. After treat- 
ment, the membranes were pelleted by centrifugation, then 
membrane associated and free 35S-LBP were quantitated by 
immunoprecipitation with the anti-LBP antibody as de- 
scribed in Materials and Methods. The results of this analy- 
sis are shown in Fig. 7. LBP was not released from chick 
muscle membranes under the conditions of this assay unless 
perturbants were added. EDTA and high salt (1 M NaC1) did 
not release LBP suggesting that divalent cation-mediated and 
electrostatic nteractions were not sufficient o account for 
the LBP-muscle membrane fraction association. Raising the 
pH in low ionic strength buffer (10 mM Na2CO3) released 
,o20% of the LBP while treatment with 0.1 N NaOH 
released ,o80% of the membrane associated LBP. Treatment 
with 4 M guanidine HCI released 100% of the LBP to the 
sup rnatant. Thus, guanidine HCI was the most effective re- 
agent for disrupting the LBP-muscle membrane fraction as- 
sociation. 
In addition to determining what conditions resulted in LBP 
release from a purified muscle fraction, two other types of 
experiments were used to assess the hydrophobic character 
of the LBP. These included association with artificial lipo- 
somes (Racker et al., 1979) and Triton X-114 partitioning 
(Alcaraz et al., 1984). To examine the interaction of purified 
LBP with artificial ipid vesicles, the protein was radioiodi- 
nated by the Iodogen method and allowed to interact with 
artificial iposomes as described in Materials and Methods 
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Figure 8. LBP interaction with artificial liposomes. Lecithin vesi- 
cles were prepared and incubated with radioiodinated proteins; 
purified LBP (A), glycophorin (C), or BSA (D). The protein lipo- 
some mixtures (closed circles) or protein alone (open circles) were 
then analyzed on discontinuous sucrose gradients (10, 30, and 45 %) 
to separate iiposome associated protein from nonassociated protein. 
B shows the effect of 0.1 N NaOH, pH 10.5-12, on the LBP/lipo- 
some association. 
(Lesot et al., 1983). The liposome/protein mixture was then 
analyzed by sucrose gradient under conditions where lipo- 
somes with associated proteins would be well separated from 
unassociated protein. Glycophorin and BSA were used as 
positive and negative controls, respectively. The results how 
that approximately half of the purified glycophorin migrated 
with artificial iposomes (Fig. 8 C), as expected from the 
data of the other workers (MacDonald and MacDonald, 
1975), while BSA did not associate with vesicles (Fig. 8 D). 
Approximately 65 % of the total LBP added to the artificial 
liposomes migrated with the lipid vesicles (Fig. 8 A). Under 
no conditions did protein migrate near the top of the sucrose 
gradient unless liposomes were present (Fig. 8, A-D, open 
circles). Similar results have been obtained previously for a 
different LBP isolated from skeletal muscle (Lesot et al., 
1983). 
The interaction of chick LBP with artificial iposomes in 
the presence of various chemical perturbants was analyzed. 
As with natural muscle membranes, the LBP could be re- 
moved from artificial iposomes with 0.1 N NaOH (Fig. 8 
B), whereas high salt (2 M KC1) was ineffective (data not 
shown). These findings indicate that there is a tight associa- 
tion between the LBP and the artificial iposomes and also 
indicate that the forces mediating this association are similar 
to those mediating the association of the LBP with natural 
membranes (cf. Fig. 7). 
Partitioning of z2SI-LBP in detergent-poor and -rich 
phases of a Triton X-114 solution was analyzed as a measure 
of the hydrophobic nature of the native protein. Glycophorin 
Table IV. Protein Partitioning in Triton X-114 
Detergent-poor phase Detergent-rich p ase 
(Hydrophilic) (Hydrophobic) 
% % 
LBP 90 10 
Glycophorin 49 51 
BSA 95 5 
Radioiodinated purified proteins, LBP, BSA, or glycophorin, were mixed with 
Triton X-II4 under conditions where partitioning into hydrophilic and 
hydrophobic Triton X-114 phases would occur (Alcaraz et al., 1984). The two 
phases were separated by centrifugation a d the relative concentration f pro- 
tein in each phase was determined by gamma counting. SDS-PAGE analysis 
of LBP recovered after the experiment showed that no degradation of the LBP 
occurred uring the experiment. 
and BSA were used as positive and negative controls respec- 
tively (Alcaraz et al., 1984). As expected, '~50% of the 
glycophorin was found in the lower hydrophobic phase while 
virtually all of the BSA was recovered in the hydrophilic, de- 
tergent poor phase (Table IV). Approximately 90% of the 
'25I-LBP was recovered in the hydrophilic phase, indicating 
that the LBP surface is predominantly h drophilic in nature 
(Alcaraz et al., 1984). 
Laminin-binding Characteristics of LBP 
Laminin is a multifunctional extracellular matrix protein and 
is known to interact with several other molecules, both on 
the cell surface and in the matrix. In some cases the precise 
laminin domain mediating these interactions has been 
identified (Rao et al., 1982; Terranova et al., 1983; Timpl 
et al., 1983; Edgar et al., 1984). Since the LBP interacted 
with laminin (see Fig. 1) but not collagen IV or fibronectin, 
in protein blots (data not shown), this method could also be 
used to identify laminin fragments that interacted with the 
LBP (Lesot et al., 1983). Laminin fragments prepared as 
previously described (Ott et al., t982) were radioiodinated 
(Fraker and Speck, 1978) and used as ligands. The results 
presented in Fig. 9 show that laminin interacted strongly 
with purified rat (lane 2) and chick (lane 3) LBP and with 
rat LBP in a muscle xtract sample (lane 1, Fig. 9). Laminin 
fragment E3 also interacted with chick LBP (lane 4) and rat 
LBP (lane 5) but laminin fragment El, which contains acell- 
binding domain for an M, 68,000 laminin receptor (Rao et 
al., 1982; Timpl et al., 1983; Graf et al., 1987) did not 
(lanes 6 and 7). The failure of fragment E1 to interact with 
the LBP is unlikely to reflect denaturation, since this prepa- 
ration was able to support he attachment of mouse mam- 
mary tumor epithelial cells and a number of other cells 
(Hall, D., C. Damsky, and L. F. Reichardt, unpublished 
observations). 
Discussion 
Homologous LBPs were isolated from rat and chick skeletal 
muscle by procedures that resulted in sufficient amounts of 
each protein for biochemical characterization. The purified 
protein bound laminin, but not fibronectin or collagen IV. 
Although the rat LBP purifed by this procedure is similar 
in apparent molecular mass to LBPs from rat muscle 
(67,000; Lesot et al., 1983), murine fibrosarcoma cells 
(69000; Malinoff and Wicha, 1983), murine melanoma 
(67,000; Rao et al., 1983) and human breast carcinoma cells 
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Figure 9. Interaction of skeletal muscle 
LBP with laminin. The figure shows an 
autoradiograph of a protein blot f LBP 
with 125I-laminin and ~25I-laminin frag- 
ments. Rat skeletal muscle extract (lane 
1), rat skeletal muscle LBP (lanes 2, 5, 
and 7) and chick s eletal muscle LBP 
(lanes 3, 4, and 6) were separated by 
SDS-PAGE, transferred to nitrocellulose. 
Sections of the nitrocellulose were incu- 
bated with J25I-laminin (lanes 1-3), 125I- 
E3 (lanes 4 and 5) or I25I-E1 (lanes 6 and 
7). Lanes 6 and 7 were exposed longer to 
ensure the absence of ligand binding. 
(60,000-75,000; Terranova et al., 1983), it appears to be a 
different protein. First, he relative molecular mass of this 
LBP does not change under nonreducing conditions as does 
the murine fibrosarcoma cell laminin receptor (Malinoff and 
Wicha, 1983). Second, although previously described LBP 
from rat skeletal muscle has a high proportion of acidic 
amino acids and binds strongly to lipid vesicles, it has a very 
distinct amino acid composition (Lesot et al., 1983). Finally, 
comparison of a partial sequence of a laminin receptor iso- 
lated from human carcinoma cells (Wewer et al., 1986) with 
the complete sequence of the LBP that is the subject of this 
paper shows no similarity (Clegg et al., 1988). While this 
LBP is clearly different from these other proteins, it is not 
yet clear whether they share significant homologies. 
Analysis of the amino acid composition of the chick and 
rat LBPs (Table II) and nucleic acid sequence analysis of two 
cDNAs encoding the chick LBP (Clegg et al., 1988) indi- 
cated that both rat and chick LBP have high negative charge 
densities. Both the chick and rat LBP have high affinity for 
DEAE-cellulose and hydroxylapatite. In addition, the avian 
LBP has a long COOH-terminal poly-asp sequence that 
would be extremely anionic (Clegg et al., 1988). It will be 
interesting to determine whether this sequence is important 
in promoting binding of LBP to laminin at the E3 domain 
which is known to contain a site capable of binding the poly- 
anion heparin (Ott et al., 1982). 
The LBPs that were independently isolated from chick and 
rat skeletal muscle were shown to be homologous by tryptic 
peptide mapping, amino acid composition, and by NH2-ter- 
minal sequence analyses. The proteins, however, are not 
identical and differ in apparent molecular mass. Heart was 
the only other tissue that had a protein that was recognized 
by the anti-LBP antiserum. The heart LBPs from both rat 
and chick, had a relative molecular mass of'~60,000. Immu- 
nochemistry and immunoelectron microscopy demonstrated 
a similar distribution for the heart and skeletal muscle LBP's 
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(Figs. 5 and 6). The failure to detect the LBP in several non- 
muscle tissues examined suggests that this protein may be a 
muscle-specific protein. The RNA encoding this protein is 
also primarily found in skeletal and cardiac muscle (Clegg 
et al., 1988). 
Several lines of evidence suggest that the LBPs in this pa- 
per are localized in the extracellular matrix in close associa- 
tion with the plasma membrane. The LBP is present in 
purified muscle membrane fractions, and is efficiently ex- 
tracted by either detergent or by 4 M GuHCI, an effective x- 
traction reagent for extracellular matrix proteins. Light and 
electron microscopy of muscle sections immunostained with 
the anti-LBP antibody suggested an extracellular distribu- 
tion, though resolution was not sufficient to distinguish be- 
tween a distribution in the muscle plasma membrane or the 
extracellular matrix (Figs. 5 and 6). 
The LBP has properties consistent with an association 
with the muscle plasma membrane, characteristic of a pe- 
ripheral, but not an integral, membrane protein. Purified 
muscle membranes containing the LBP, were treated with a 
variety of agents known to disrupt different membrane/pro- 
tein interactions. The LBP was removed by high pH and 
chaotrophs, reagents that would not remove proteins interca- 
lated in the lipid bilayer. Experiments with artificial lipo- 
somes showed that purified LBP interacted with lipid vesi- 
cles and was removed by high pH but not high salt. These 
experiments suggest that similar interactions are responsible 
for the association of LBP with muscle membranes and with 
liposomes. Assays of surface hydrophobicity b  partitioning 
of LBP in Triton X-114 demonstrated that the LBP did not 
partition into the hydrophobic phase. Thus the LBP has an 
unusual combination of properties: it interacts strongly with 
liposomes and natural membranes but partitions in the aque- 
ous phase of Triton X-114. SDS-PAGE analysis of the LBP 
recovered from the Triton X-114 experiment showed that the 
protein had not been degraded (data not shown). Further- 
more, there is precedence for membrane proteins to partition 
in the aqueous phase of Triton X-114 (Maher and Singer, 
1985). The hydrophilic nature of the LBP, suggested by Tri- 
ton X-114 partitioning, and lack of a hydrophobic amino acid 
sequence long enough to serve as a transmembrane domain 
(Clegg et al., 1988) are consistent with a peripheral, but not 
an integral membrane localization. These experiments sug- 
gest hat the LBP binds the muscle plasmalemma and the ex- 
tracellular matrix protein, laminin. 
Radioiodinated laminin fragments were used to determine 
which laminin domain interacted with the LBP. Laminin 
fragment E3, containing the heparin binding domain (Ott et 
al., 1982), but not laminin fragment E1 containing a cell- 
binding domain (Timpl et al., 1983; Rao et al., 1982) was 
found to interact with the LBP in protein blots. Substrate 
bound E1 fragment was able to support umor cell attach- 
ment indicating that the fragment was biologically active 
(data not shown). The interaction of the LBP with laminin 
is probably not via the unusual gal ~tl-3 gal carbohydrate 
found on murine laminin, since the LBP failed to bind to 
an affinity matrix containing this carbohydrate (data not 
shown). The LBP has a very high negative charge density 
and may therefore interact with what has been called the 
heparin-binding domain of the laminin molecule. This site 
of interaction also distinguishes the protein from a previ- 
ously described laminin receptor which appears to bind a do- 
main in a short arm (B1 chain) of the laminin molecule (Graf 
et al., 1987). 
The rat and chick LBPs described in this paper are muscle 
proteins that bind laminin and are distributed extracellularly 
in the tissue near the plasma membrane and extracellular 
matrix. Thus they are proteins well placed to interact with 
laminin in vivo. Presently, no function is known for these 
LBPs though they may mediate cell interactions with laminin 
in the extracellular matrix, performing the function of a 
laminin receptor as proposed for other proteins with similar 
characteristics. Alternatively, the LBP could be a protein that 
binds to laminin and modulates the interaction of laminin 
with other matrix or cell surface molecules in the microen- 
vironment near the cell surface or in the muscle basal amina. 
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